Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
-
Shares outstanding
-
9,036,176
-
Total 13F shares
-
15,975,265
-
Share change
-
+193,872
-
Total reported value
-
$400,530,030
-
Price per share
-
$25.08
-
Number of holders
-
38
-
Value change
-
+$3,105,150
-
Number of buys
-
22
-
Number of sells
-
29
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) as of Q3 2020
As of 30 Sep 2020,
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,975,265 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Casdin Capital, LLC, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, BAILLIE GIFFORD & CO, CANADA PENSION PLAN INVESTMENT BOARD, PRICE T ROWE ASSOCIATES INC /MD/, AMERIPRISE FINANCIAL INC, JENNISON ASSOCIATES LLC, Hudson Bay Capital Management LP, and HSBC HOLDINGS PLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.